Supreme Court decides Myriad human gene patenting case
by Science to Law • June 13, 2013 • S2L
A unanimous Supreme Court today held that isolated human genes are products of nature and cannot be patented under 35 USC 101, although cDNA (complementary DNA) can be.
We’ve been following the Myriad case as it made its way through the courts. We will cover this development in more depth soon — for now, here’s the news:
Justices, 9-0, bar patenting human genes [New York Times]
Permalink: Comment or share →